Clinical Trial Update: Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial evaluating the safety and preliminary efficacy of GEN1055 in malignant solid tumors (as monotherapy and in combination) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• GEN1055

Snippet

Sponsor: Genmab | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: TERMINATED